KARDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Kardigan, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 11, 2026
$12.94−0.09 (-0.69%)
Close on Oct 19, 2026
- Market cap
- $326.04M
- P/E (TTM)
- –
- Dividend yield
- –
About Kardigan
Pharmaceutical Preparations, SIC 2834
Kardigan, Inc. is listed on Nasdaq under the ticker KARD, in the SEC industry Pharmaceutical Preparations. It is incorporated in Delaware and its fiscal year ends on December 31. Reported financials on StockData start in fiscal 2024.
Company profile
Company
- Legal name
- Kardigan, Inc.
- Headquarters
- South San Francisco, CA
- Address
- C/O Kardigan, Inc., 131 Oyster Point Blvd., Second Floor 94080
- Phone
- (415) 573-3220
- Website
- kardigan.bio
- Industry
- Pharmaceutical Preparations
- Incorporated in
- Delaware
- Fiscal year ends
- December 31
Stock & identifiers
- Ticker
- KARD
- Exchange
- Nasdaq
- IPO date
- Jun 18, 2026
- Shares outstanding
- 94M, Aug 7, 2026
- Filer category
- <br>Emerging growth company
- SEC CIK
- 2123613
- CUSIP
- 485925101
- ISIN
- US4859251013
- EIN
- 93-2994203
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| Anastasios Gianakakos | President & CEO, Director | 9,806,633 |
| Jay Edelberg | Chief Medical Officer | 4,595,383 |
| John B. Moriarty | Chief Legal Officer | 47,784 |
| Brianne Jahn | Chief Financial Officer | 79,640 |
| Andy Pasternak | Chief Strategy Officer | 79,640 |
| Capital Solutions Holdings LP Perceptive | Director | – |
| Life Sciences Master Fund Ltd Perceptive | Director | – |
| Advisors Llc Perceptive | Director | – |
| Joseph Edelman | Director | 20,706 |
| Robert Nelsen | Director | 15,042,035 |
| Paul L. Berns | Director | 15,062,741 |
| ARCH Venture Partners XIII, LLC | Director | – |
| ARCH Venture Fund XIII, L.P. | Director | – |
| ARCH Venture Partners XIII, L.P. | Director | – |
| Steven Gillis | Director | – |
| Keith Crandell | Director | – |
| Kristina Burow | Director | – |
| Timothy P. Walbert | Director | 20,706 |
| Kimberly J. Popovits | Director | 20,706 |
| David P. Meeker | Director | 20,706 |
| Douglas E. Giordano | Director | 20,706 |
Corporate history
Events identified from SEC filings
| Date | Event | Details |
|---|---|---|
| Jun 18, 2026 | IPO | Initial public offering priced (424B4 prospectus) |
| Jun 15, 2026 | Listing | Registration of securities on an exchange (Form 8-A) |